Tools

LEADER 02988cam a2200529 i 4500

001 on1236207366;

003 OCoLC;

005 20210615155109.0;

006 m o d f ;

007 cr |||||||||||;

008 210205s2021 dcua ob f000 0 eng c;

024 8 a| 40-634q| (GPO jacket number);

035 a| (Sirsi) o1236207366;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

050 4 a| KF27b| .S39 2020d;

074 a| 1025-A-03 (online);

086 0 a| Y 4.SCI 2:116-74;

088 a| Serial no. 116-74 (United States. Congress. House. Committee on Science, Space, and Technology (2011- ));

245 10 a| Repurposing therapeutic drugs for COVID-19 :b| research challenges and opportunities : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, second session, June 19, 2020.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2021.;

300 a| 1 online resource (iii, 75 pages) :b| illustration;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Access ID (govinfo): CHRG-116hhrg40634.;

500 a| "Serial no. 116-74.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Dr. Peter Lurie, President, Center for Science in the Public Interest; Dr. James Finigan, Director of the Respiratory Centers of Excellence, National Jewish Health; Dr. Rick L. Stevens, Associate Laboratory Director for Computing, Environment and Life Sciences, Argonne National Laboratory; Dr. Benjamin Rome, Associate Physician, Brigham and Women's Hospital; Postdoctoral Research Fellow, Harvard Medical School.;

518 a| Date of hearing: 2020-06-19.;

588 a| Description based on online resource; title from PDF title page (govinfo, viewed Feb. 3, 2021).;

650 0 a| Drugsx| Researchz| United States.=| ^A1001118;

650 0 a| COVID-19 (Disease)z| United States.=| ^A1407776;

650 0 a| COVID-19 (Disease)x| Treatmentz| United States.=| ^A1407776;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Science, Space, and Technology (2011- ). Subcommittee on Investigations and Oversight.t| Repurposing therapeutic drugs for COVID-19w| (OCoLC)1241089296;

856 40 u| https://purl.fdlp.gov/GPO/gpo151186;

922 a| BIBCONEW;

922 a| GOVINFOHRG;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5569651;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5569651-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 3/12/2021x| EDOCUMENTz| JERESOURCE;

Repurposing therapeutic drugs for COVID-19 : research challenges and opportunities : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, second session, June 19, 2020.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2021.
Description	1 online resource (iii, 75 pages) : illustration
Supplemental Content	https://purl.fdlp.gov/GPO/gpo151186
Subjects	Drugs--Research. --United States. COVID-19 (Disease)--United States. COVID-19 (Disease)--Treatment. --United States.

General note	Access ID (govinfo): CHRG-116hhrg40634.
General note	"Serial no. 116-74."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Dr. Peter Lurie, President, Center for Science in the Public Interest; Dr. James Finigan, Director of the Respiratory Centers of Excellence, National Jewish Health; Dr. Rick L. Stevens, Associate Laboratory Director for Computing, Environment and Life Sciences, Argonne National Laboratory; Dr. Benjamin Rome, Associate Physician, Brigham and Women's Hospital; Postdoctoral Research Fellow, Harvard Medical School.
Date/time/place of a event note	Date of hearing: 2020-06-19.
Source of description	Description based on online resource; title from PDF title page (govinfo, viewed Feb. 3, 2021).
Issued in other form	Print version: United States. Congress. House. Committee on Science, Space, and Technology (2011- ). Subcommittee on Investigations and Oversight. Repurposing therapeutic drugs for COVID-19
Genre/form	Legislative hearings.
Standard identifier#	40-634 (GPO jacket number)
Technical rpt number	Serial no. 116-74 (United States. Congress. House. Committee on Science, Space, and Technology (2011- ))
GPO item number	1025-A-03 (online)
Govt. docs number	Y 4.SCI 2:116-74

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Repurposing therapeutic drugs for COVID-19 : research challenges and opportunities : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, second session, June 19, 2020.

Click here for more information about this title

Availability